Wojciech Płonka

Wojciech Płonka

Auto-generated profile, based on publicly available information

Wojciech Płonka

Independent Public Health Care Facility MSWiA in Opole, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
PBPaulina Bednarczyk
Paulina Bednarczyk
DCDamian Aleksander Chruścicki
Damian Aleksander Chruścicki
MPMarcin Tomasz Pelc
Marcin Tomasz Pelc
GSGracjan Sitarek
Gracjan Sitarek
MŻMarta Żerek
Marta Żerek
WPWojciech Płonka
Wojciech Płonka
Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition marked by painful nodules and abscesses. It frequently coexists with autoimmune diseases, complicating management. Autoimmune conditions such as thyroid disorders, irritable bowel syndrome (IBS), systemic lupus erythematosus (SLE), and psoriasis are common in HS patients, necessitating a comprehensive care approach. Aim of the Study: This review evaluates the prevalence and impact of autoimmune diseases—autoimmune thyroid disorders, IBS, SLE, and psoriasis—on individuals with HS. Materials and Methods: A literature search of PubMed, Scopus, and Web of Science from 2018 to 2024 identified studies relevant to HS co-morbidities based on quality and relevance. Results: HS shows significant links with autoimmune thyroid disorders, IBS, SLE, and psoriasis. HS patients often have higher rates of hypothyroidism, hyperthyroidism, IBS, and SLE compared to the general population, suggesting shared inflammatory mechanisms. Conclusion: Recognizing co-morbid autoimmune diseases is vital for effective HS management. These associations emphasize the need for a multidisciplinary approach and further research to enhance understanding and treatment strategies.

10 October 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
DCDamian Aleksander Chruścicki
Damian Aleksander Chruścicki
PBPaulina Bednarczyk
Paulina Bednarczyk
WKWojciech Kulej
Wojciech Kulej
WPWojciech Płonka
Wojciech Płonka
MPMarcin Tomasz Pelc
Marcin Tomasz Pelc
JWJakub Waszczyński
Jakub Waszczyński
Introduction Buerger's disease (BD) is an inflammatory disease with an etiology that is still not fully understood. It involves venous and arterial vessels, of small and medium caliber, of the lower and upper extremities (Cacione et al., 2020). This inflammation predominantly affects young, tobacco-smoking men, usually those before the age of 40. Literature data relating to peripheral arterial disease in general, put the prevalence of BD at between 0.5%-5.6% in Western European countries (Liu et al., 2023; Öztan et al., 2023). In this paper, we summarized the latest literature reports on rare clinical images and new directions in the treatment of Buerger's disease. Aim of the study The purpose of this systematic review was to compile the latest literature on the etiology, atypical disease presentation, associations with other diseases and modern treatment of Buerger's disease. Materials and methods The materials used by our team were obtained from a review of the currently available literature in the PubMed database. To search for articles, we used keywords such as: Buerger’s disease, thromboangiitis obliterans, thrombosis, atherosclerosis, Peripheral arterial disease, vasculitis. Conclusion In addition to its characteristic clinical presentation, Buerger's disease can present under a number of atypical forms. Such examples, less common conditions in the course of BD are intestinal vascular involvement mimicking the condition of acute abdomen, infertility condition due to gonadal involvement in the patient, possible correlation between the level of ASA (anti-sperm antibodies) and reduced fertility, the occurrence of nail lesions, renal complications, including the nephrotic syndrome, ocular or psychiatric manifestations. It is important for the clinician, in the diagnostic and therapeutic process at the onset of the described symptoms, not to exclude the possibility of an uncommon course of BD, to make a correct diagnosis and undertake optimal treatment.

12 May 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
WPWojciech Płonka
Wojciech Płonka
MPMarcin Tomasz Pelc
Marcin Tomasz Pelc
GSGracjan Sitarek
Gracjan Sitarek
MŻMarta Żerek
Marta Żerek
MBMonika Bułatowicz
Monika Bułatowicz
APAleksandra Pławiak
Aleksandra Pławiak
Introduction Cardiovascular diseases are the most numerous group of diseases prevalent in the world. They are a challenge for many health systems, in terms of keeping life comfortable and also economics. The cause of selected disease entities is too much cholesterol in the blood. The most popular treatment for hypercholesterolemia is based on statins. Many patients are affected by intolerance to these drugs, so an important issue is the discovery and improvement of alternatives to statins. Purpose of work The purpose of this review is to collect literature data on the latest treatments for hypercholesterolemia with drugs other than statins and ezetimibe. Materials and methods Materials are from a review of recent literature available in PubMed. To search for articles, we used keywords such as: bempedoic acid, non-statin therapy, cardiovascular risk, inclisiran, alirocumab, cardiovascular disease, dyslipidemia, evolocumab. Summary Treatment of hypercholesterolemia with statins remains the most popular management strategy. Intolerance to treatment with these drugs creates serious clinical problems for patients. Recently, we could see the emergence of new drugs as alternatives to statins. As the results show, the new drugs can effectively replace statins in the hypolipemic treatment especially of patients who cannot be treated with them.

25 September 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
GSGracjan Sitarek
Gracjan Sitarek
MŻMarta Żerek
Marta Żerek
WPWojciech Płonka
Wojciech Płonka
DCDamian Aleksander Chruścicki
Damian Aleksander Chruścicki
PBPaulina Bednarczyk
Paulina Bednarczyk
MPMarcin Tomasz Pelc
Marcin Tomasz Pelc
A desmoid tumor is a clonal fibroblast proliferation, occurring in deep soft tissues with a significant recurrence tendency. Aggressive fibromatosis is a rare disease. The prevalence in the population ranges from 2 to 4 cases per million. Mentioned neoplasms are highly unpredictable in terms of development. Typically, in the course of desmoid tumors, metastases do not occur, but they often infiltrate the surrounding tissues, which may be associated with numerous complications. There are currently no randomized standards of therapy designated, which is undoubtedly a challenge when referring to treatment. To a 37 year old patient, due to a pathological mass in the abdomen, the MR examination was performed. It showed the presence of an irregular, heterogeneous structure on the right side of the abdominal cavity. A laparotomy was performed. During the procedure adhesions were released and the giant abdominal tumor was removed in one block with part of the duodenum, caecum, ascending colon and part of ileum. End-to-end duodenal anastomosis and stapled, side-to-side ileo-transverse anastomosis were used. The surgical field was being drained. The postoperative course was uneventful. Tissue material was collected for a routine, histopathological examination in which the intra-abdominal form of fibromatosis was diagnosed. The macroscopic image describes a tumor with dimensions of 25.0 cm x 25.0 cm x 20.0 cm.

11 October 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MŻMarta Żerek
Marta Żerek
GSGracjan Sitarek
Gracjan Sitarek
WPWojciech Płonka
Wojciech Płonka
DCDamian Aleksander Chruścicki
Damian Aleksander Chruścicki
PBPaulina Bednarczyk
Paulina Bednarczyk
MPMarcin Tomasz Pelc
Marcin Tomasz Pelc
Pulmonary-renal syndrome is called alveolar hemorrhage accompanied by glomerulonephritis. The above condition can occur as a manifestation of ANCA-associated granulomatosis with vasculitis. The course of the disease varies from mild, limited inflammation to rapid progression with multi-organ changes that can be life-threatening. The mainstay of therapy is immunosuppression - both in the acute phase of the disease and after clinical improvement. Unfortunately, common causes of death in addition to complications of the disease include side effects of immunosuppressive treatment. A 72-year-old man is transferred to the Nephrology Unit for acute kidney injury of unclear etiology. On the basis of clinical examination, laboratory and imaging studies, a diagnosis of systemic small vessel inflammation with c-ANCA occupying the kidneys, lungs and intestines was made. Due to acute respiratory failure, the patient was transferred to the ICU, where renal replacement therapy, plasmapheresis, steroid pulses and cyclophosphamide were administered. After clinical improvement, it was decided to continue cyclophosphamide therapy and monitor blood IgG levels. Unfortunately, 4 months later, the patient died of multiple organ failure caused by septic shock of bacterial etiology. In the described case, age and comorbidities were the biggest risk factors for infectious complications of immunosuppression. The population is aging, so it is necessary to analyze the current standards of immunosuppressive treatment to improve the prognosis of the elderly.